Synthetic biology investment in the midwest topped the Bay Area in Q1 by John Murray at Synbiobeta
Whether it’s Motown music or Boston biotech, innovation happens quicker in some places than others. And in synthetic biology, Boston and the Bay Area have always set the pace. The reasons are well known. Decades of smart policy decisions paved the way for today’s virtuous circle of innovation and investment. But Q1 funding for synthetic biology brought some surprises. Keep reading.









Davis soil-science startup Pheronym Inc. will test its biological pest controls in orbit later this year as part of a mission on the International Space Station.







